Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Vascular endothelial growth factor receptor 2 (VEGFR2) correlates with long-term survival in patients with advanced high-grade serous ovarian cancer (HGSOC): a study from the Tumor Bank Ovarian Cancer (TOC) Consortium.

Guan J, Darb-Esfahani S, Richter R, Taube ET, Ruscito I, Mahner S, Woelber L, Prieske K, Concin N, Vergote I, Van Nieuwenhuysen E, Achimas-Cadariu P, Glajzer J, Woopen H, Stanske M, Kulbe H, Denkert C, Sehouli J, Braicu EI.

J Cancer Res Clin Oncol. 2019 Feb 27. doi: 10.1007/s00432-019-02877-4. [Epub ahead of print]

PMID:
30810838
2.

Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.

Polterauer S, Schwameis R, Grimm C, Hillemanns P, Jückstock J, Hilpert F, de Gregorio N, Hasenburg A, Sehouli J, Fürst ST, Strauß HG, Baumann K, Thiel F, Mustea A, Harter P, Wimberger P, Kölbl H, Reinthaller A, Woelber L, Mahner S.

Gynecol Oncol. 2019 Feb 11. pii: S0090-8258(19)30112-X. doi: 10.1016/j.ygyno.2019.02.007. [Epub ahead of print]

PMID:
30760408
3.

Comparison of PapilloCheck and Linear Array to Detect and Differentiate Human Papillomaviruses in Cervical and Tonsillar Smears from Females with Cervical Intraepithelial Lesions.

Grimm D, Woelber L, Prieske K, Schmalfeldt B, Kürti S, Busch CJ, Teudt I, Brummer O, Mueller V, Meyer T.

Eur J Microbiol Immunol (Bp). 2018 Dec 12;8(4):107-111. doi: 10.1556/1886.2018.00018. eCollection 2018 Dec 23.

4.

Superficially invasive stage IA vulvar squamous cell carcinoma-therapy and prognosis.

Grimm D, Prieske K, Mathey S, Kuerti S, Burandt E, Schmalfeldt B, Woelber L.

Int J Gynecol Cancer. 2019 Mar;29(3):466-473. doi: 10.1136/ijgc-2018-000046. Epub 2019 Jan 4.

PMID:
30622111
5.

Sexual activity and quality of life in patients after treatment for breast and ovarian cancer.

Mayer S, Iborra S, Grimm D, Steinsiek L, Mahner S, Bossart M, Woelber L, Voss PJ, Gitsch G, Hasenburg A.

Arch Gynecol Obstet. 2019 Jan;299(1):191-201. doi: 10.1007/s00404-018-4922-2. Epub 2018 Nov 1.

PMID:
30386993
6.

Participation of elderly gynecological cancer patients in clinical trials.

Prieske K, Trillsch F, Oskay-Özcelik G, Chekerov R, Bleich C, Oliveira-Ferrer L, Grimm D, Kuerti S, Mueller V, Suling A, Schmalfeldt B, Sehouli J, Mahner S, Woelber L.

Arch Gynecol Obstet. 2018 Oct;298(4):797-804. doi: 10.1007/s00404-018-4886-2. Epub 2018 Aug 30.

PMID:
30167853
7.

Correlation of Isotope Count With Sentinel Node Positivity in Vulvar Cancer.

Woelber L, Joosse SA, Grimm D, Mathey S, Mahner S, Burandt E, Klutmann S, Schmalfeldt B, Prieske K.

Int J Gynecol Cancer. 2018 Sep;28(7):1403-1409. doi: 10.1097/IGC.0000000000001298.

PMID:
29923853
8.

Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer.

Prieske K, Prieske S, Joosse SA, Trillsch F, Grimm D, Burandt E, Mahner S, Schmalfeldt B, Milde-Langosch K, Oliveira-Ferrer L, Woelber L.

Oncotarget. 2017 Sep 15;8(47):83063-83074. doi: 10.18632/oncotarget.20945. eCollection 2017 Oct 10.

9.

Antibody persistence and evidence of immune memory at 5years following administration of the 9-valent HPV vaccine.

Guevara A, Cabello R, Woelber L, Moreira ED Jr, Joura E, Reich O, Shields C, Ellison MC, Joshi A, Luxembourg A.

Vaccine. 2017 Sep 5;35(37):5050-5057. doi: 10.1016/j.vaccine.2017.07.017. Epub 2017 Aug 5.

PMID:
28789851
10.

VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patients.

Kuerti S, Oliveira-Ferrer L, Milde-Langosch K, Schmalfeldt B, Legler K, Woelber L, Prieske K, Mahner S, Trillsch F.

Oncotarget. 2017 Jun 27;8(26):43218-43227. doi: 10.18632/oncotarget.17978.

11.

Oral Human Papillomavirus in Women With High-Grade Cervical Intraepithelial Neoplasia.

Woelber L, Breuer J, Meyer T, Vettorazzi E, Prieske K, Bohlmann I, Busch CJ, Teudt I, Brummer O, Mueller V, Schmalfeldt B, Grimm D.

J Low Genit Tract Dis. 2017 Jul;21(3):177-183. doi: 10.1097/LGT.0000000000000313.

PMID:
28481782
12.

European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer.

Oonk MHM, Planchamp F, Baldwin P, Bidzinski M, Brännström M, Landoni F, Mahner S, Mahantshetty U, Mirza M, Petersen C, Querleu D, Regauer S, Rob L, Rouzier R, Ulrikh E, van der Velden J, Vergote I, Woelber L, van der Zee AGJ.

Int J Gynecol Cancer. 2017 May;27(4):832-837. doi: 10.1097/IGC.0000000000000975.

PMID:
30814182
13.

European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer.

Oonk MHM, Planchamp F, Baldwin P, Bidzinski M, Brännström M, Landoni F, Mahner S, Mahantshetty U, Mirza M, Petersen C, Querleu D, Regauer S, Rob L, Rouzier R, Ulrikh E, van der Velden J, Vergote I, Woelber L, van der Zee AGJ.

Int J Gynecol Cancer. 2017 May;27(4):832-837. doi: 10.1097/IGC.0000000000000975.

PMID:
28441255
14.

Preference of elderly patients' to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial.

Chekerov R, Harter P, Fuxius S, Hanker LC, Woelber L, Müller L, Klare P, Abenhardt W, Nedkova Y, Yalcinkaya I, Heinrich G, Sommer H, Mahner S, Wimberger P, Koensgen-Mustea D, Richter R, Oskay-Oezcelik G, Sehouli J; Ovarian Cancer Study Group of the North-Eastern German Society of Gynaecological Oncology (NOGGO).

Gynecol Oncol Res Pract. 2017 Mar 7;4:6. doi: 10.1186/s40661-017-0040-2. eCollection 2017.

15.

Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study.

Woelber L, Griebel LF, Eulenburg C, Sehouli J, Jueckstock J, Hilpert F, de Gregorio N, Hasenburg A, Ignatov A, Hillemanns P, Fuerst S, Strauss HG, Baumann KH, Thiel FC, Mustea A, Meier W, Harter P, Wimberger P, Hanker LC, Schmalfeldt B, Canzler U, Fehm T, Luyten A, Hellriegel M, Kosse J, Heiss C, Hantschmann P, Mallmann P, Tanner B, Pfisterer J, Richter B, Neuser P, Mahner S.

Eur J Cancer. 2016 Dec;69:180-188. doi: 10.1016/j.ejca.2016.09.038. Epub 2016 Nov 10.

PMID:
27837710
16.

Propensity Scoring after Multiple Imputation in a Retrospective Study on Adjuvant Radiation Therapy in Lymph-Node Positive Vulvar Cancer.

Eulenburg C, Suling A, Neuser P, Reuss A, Canzler U, Fehm T, Luyten A, Hellriegel M, Woelber L, Mahner S.

PLoS One. 2016 Nov 1;11(11):e0165705. doi: 10.1371/journal.pone.0165705. eCollection 2016.

17.

Patterns of distant metastases in vulvar cancer.

Prieske K, Haeringer N, Grimm D, Trillsch F, Eulenburg C, Burandt E, Schmalfeldt B, Mahner S, Mueller V, Woelber L.

Gynecol Oncol. 2016 Sep;142(3):427-34. doi: 10.1016/j.ygyno.2016.07.009. Epub 2016 Jul 9.

PMID:
27401841
18.

The Risk of Contralateral Non-sentinel Metastasis in Patients with Primary Vulvar Cancer and Unilaterally Positive Sentinel Node.

Woelber L, Eulenburg C, Grimm D, Trillsch F, Bohlmann I, Burandt E, Dieckmann J, Klutmann S, Schmalfeldt B, Mahner S, Prieske K.

Ann Surg Oncol. 2016 Aug;23(8):2508-14. doi: 10.1245/s10434-016-5114-6. Epub 2016 Feb 8.

PMID:
26856721
19.

E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer.

Trillsch F, Kuerti S, Eulenburg C, Burandt E, Woelber L, Prieske K, Eylmann K, Oliveira-Ferrer L, Milde-Langosch K, Mahner S.

Br J Cancer. 2016 Jan 19;114(2):213-20. doi: 10.1038/bjc.2015.436.

20.

Beyond Bevacizumab: An Outlook to New Anti-Angiogenics for the Treatment of Ovarian Cancer.

Mahner S, Woelber L, Mueller V, Witzel I, Prieske K, Grimm D, Keller-V Amsberg G, Trillsch F.

Front Oncol. 2015 Oct 5;5:211. doi: 10.3389/fonc.2015.00211. eCollection 2015. Review.

Supplemental Content

Loading ...
Support Center